In the Absence of Testosterone: Hormonal Treatment, Masculinity, and Health among Prostate Cancer Patients Engaging in an Exercise Programme

被引:0
|
作者
Rindhagen, Cecilia [1 ]
Andreasson, Jesper [1 ]
Johansson, Thomas [2 ]
机构
[1] Linnaeus Univ, Dept Sport Sci, S-35195 Vaxjo, Sweden
[2] Univ Gothenburg, Dept Educ Commun & Learning, S-40530 Gothenburg, Sweden
来源
SOCIAL SCIENCES-BASEL | 2023年 / 12卷 / 07期
关键词
prostate cancer; physical activity; exercise programme; masculinity; body; ANDROGEN DEPRIVATION THERAPY; MEN; PERSPECTIVES; PERCEPTIONS; EXPERIENCES;
D O I
10.3390/socsci12070417
中图分类号
C [社会科学总论];
学科分类号
03 ; 0303 ;
摘要
This study focuses on men undergoing androgen deprivation therapy (ADT) treatment for prostate cancer who also participated in an exercise programme as part of their rehabilitation. Our aim was twofold. First, we aimed to describe and analyse how the participants talk about their treatment and its side-effects in relation to the body and masculinity. Second, we aimed to describe the participants' understanding of and motivation to participate in a physical activity programme designed by healthcare professionals to deal with anticipated and unwanted bodily changes following treatment. Focus group interviews and individual interviews were conducted. Theoretically, the study leans on phenomenological theories of embodiment combined with a sociologically informed framework found in critical studies on men and masculinity. The results showed that the medical suspension of testosterone impacted not only the men's understanding of themselves as men but also how they approached their own bodies. Testosterone was discussed as a source of masculinity and masculine traits. Consequently, the absence of testosterone following treatment led to ongoing reflections on how to understand the (ageing) body and its relationship to masculinity. The ageing ADT body, with growing breasts and a lack of libido, became a site of emasculation and bodily detachment. The men addressed this by displaying stoic masculinity; instead of addressing the problem emotionally they turned their attention and aspirations to having a capable body and being able to carry out physical work. However, participation in the exercise programme depended on recruitment by their physicians and was motivated by the opportunity to socialise with other men in the same situation.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Impact of combined novel hormonal agents on testosterone levels of patients with prostate cancer undergoing treatment with leuprorelin.
    Lages, Paulo Sergio
    de Almeida, Daniel Vargas Pivato
    Bergerot, Paulo Gustavo
    Barbosa, Michelle
    Lages, Luciana
    Morbeck, Igor Alexandre Protzner
    Zulli, Guilherme Augusto
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 95 - 95
  • [2] A testosterone-producing Leydig cell tumor metastasis during hormonal treatment of prostate cancer
    Stokkel, Laura
    van der Poel, Henk G.
    Langbein, Sigrun, I
    Kerst, J. Martijn
    de Jong, Jeroen
    van Rhijn, Bas W. G.
    UROLOGY ANNALS, 2020, 12 (02) : 180 - 183
  • [3] Treatment patterns among novel hormonal therapyexperienced patients with metastatic castration-resistant prostate cancer
    Narayan, V.
    Patel, M.
    Teitsson, S.
    Rosenblatt, L.
    Yin, X.
    Betts, K. A.
    Pivneva, I.
    Gao, S.
    Sundar, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S988 - S988
  • [4] Extraction of Treatment Information From Electronic Health Records and Evaluation of Testosterone Recovery in Patients With Prostate Cancer
    Guin, Sunny
    Jun, Tomi
    Patel, Vaibhav G.
    Ayers, Kristin L.
    Deitz, Matthew
    Cai, Yuqin
    Zhou, Xiang
    Tsao, Che-Kai
    Oh, William K.
    Chen, Rong
    Liaw, Bobby C.
    JCO CLINICAL CANCER INFORMATICS, 2022, 6
  • [5] Sleep and health improvement programme (SHIP) for patients with prostate cancer and caregivers
    Loeb, Stacy
    Robbins, Rebecca
    Sanchez-Nolasco, Tatiana
    Byrne, Nataliya
    Ruan, Andrea
    Rivera, Adrian
    Gupta, Natasha
    Kenfield, Stacey A.
    Chan, June M.
    Van Blarigan, Erin L.
    Carter, Patricia
    Jean-Louis, Girardin
    Orstad, Stephanie L.
    BJUI COMPASS, 2024, 5 (10): : 976 - 985
  • [6] RELATIONSHIP OF TESTOSTERONE TREATMENT AND INCIDENT PROSTATE CANCER RISK AMONG US VETERANS WITH LOW SERUM TESTOSTERONE
    Walsh, Thomas
    Shores, Molly
    Smith, Nicholas
    Thompson, Mary Lou
    Fox, Alexandra
    Moore, Kathryn
    Krakauer, Chloe
    Forsberg, Christopher
    Heckbert, Susan
    Matsumoto, Alvin
    JOURNAL OF UROLOGY, 2016, 195 (04): : E28 - E29
  • [7] Hormonal treatment and quality of life of prostate cancer patients: new evidence
    Tucci, Marcello
    Leone, Gianmarco
    Buttigliero, Consuelo
    Zichi, Clizia
    Di Stefano, Rosario F.
    Pignataro, Daniele
    Vignani, Francesca
    Scagliotti, Giorgio V.
    Di Maio, Massimo
    MINERVA UROLOGICA E NEFROLOGICA, 2018, 70 (02) : 144 - 151
  • [8] Treatment in the absence of disease reclassification among men on active surveillance for prostate cancer
    Kirk, Peter S.
    Zhu, Kehao
    Zheng, Yingye
    Newcomb, Lisa F.
    Schenk, Jeannette M.
    Brooks, James D.
    Carroll, Peter R.
    Dash, Atreya
    Ellis, William J.
    Filson, Christopher P.
    Gleave, Martin E.
    Liss, Michael
    Martin, Frances
    McKenney, Jesse K.
    Morgan, Todd M.
    Nelson, Peter S.
    Thompson, Ian M.
    Wagner, Andrew A.
    Lin, Daniel W.
    Gore, John L.
    CANCER, 2022, 128 (02) : 269 - 274
  • [9] TREATMENT IN THE ABSENCE OF DISEASE RECLASSIFICATION AMONG MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER
    Kirk, Peter
    Newcomb, Lisa
    Zhu, Kehao
    Zheng, Yingye
    Schenk, Jeannette
    Lin, Daniel
    Gore, John
    JOURNAL OF UROLOGY, 2021, 206 : E213 - E214
  • [10] NEW PERSONALIZED HEALTH CARE APPROACH: ENGAGING PROSTATE CANCER PATIENTS, PROVIDERS, AND PAYERS
    Drea, E. J.
    Pitluk, H.
    Thompson, S.
    Michelet, K.
    VALUE IN HEALTH, 2013, 16 (03) : A270 - A270